Ads
related to: metastatic prostate cancer treatment guidelines- Side Effect Information
Learn More About Potential Side
Effects And Safety Information.
- Oral Medication
Learn More About An Oral Treatment
For Metastatic Prostate Cancer.
- Real Patient Story
Learn How A Patient's BRCA Status
Informed His Treatment Journey.
- Clinical Study Data
Find Clinical Study Data
At The Patient Site.
- Patient Support Program
Learn About A Treatment Option
And Patient Support.
- Genomic Testing
Read How Testing Could
Help Inform Your Treatment Plan.
- Side Effect Information
Search results
Results From The WOW.Com Content Network
Surgical removal of the prostate, or prostatectomy, is a common treatment either for early-stage prostate cancer or for cancer that has failed to respond to radiation therapy. The most common type is radical retropubic prostatectomy , when the surgeon removes the prostate through an abdominal incision.
Prostate tumors were first described in the mid-19th century, during surgeries on men with urinary obstructions. Initially, prostatectomy was the primary treatment for prostate cancer. By the mid-20th century, radiation treatments and hormone therapies were developed to improve prostate cancer treatment.
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) is a clinical trial investigating treatments for high risk or terminal prostate cancer. Recruitment started in 2005 and ended in 2022; as of January 2020, over 10,000 participants had joined the trial.
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in screening guidelines. Experts weigh in on the threat to men's health.
Sipuleucel-T is indicated for the treatment of metastatic, asymptomatic or minimally symptomatic, metastatic castrate-resistant hormone-refractory prostate cancer (HRPC). ). Other names for this stage are metastatic castrate-resistant (mCRPC) and androgen independent (AI) or (A
Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Once patients are placed in prognostic categories, this information can contribute to the selection of an optimal approach ...
Ads
related to: metastatic prostate cancer treatment guidelines